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ABSTRACT 
Background and objectives 
A clinical trial in 93 NHS hospitals evaluated a quality improvement programme for emergency 
abdominal surgery, designed to improve mortality by improving the patient care pathway. Large 
variation was observed in implementation approaches and the main trial result showed no mortality 
reduction. Our objective therefore was to evaluate whether trial participation led to care-pathway 
implementation and to study the relationship between care-pathway implementation and use of six 
recommended implementation strategies.  
 
Methods 
We performed a hospital-level time-series analysis using data from the Enhanced Peri-Operative Care 
for High-risk patients (EPOCH) trial. Care-pathway implementation was defined as achievement of 
>80% median reliability in ten measured care-processes. Mean monthly process performance was 
plotted on run-charts. Process improvement was defined as an observed run-chart signal, using 
probability-based ‘shift’ and ‘runs’ rules. A new median performance level was calculated after an 
observed signal.  
 
Results 
Of 93 participating hospitals, 80 provided sufficient data for analysis, generating 800 process measure 
charts from 20,305 patient admissions over 27 months. No hospital reliably implemented all ten 
processes. Overall, only 279 of the 800 processes were improved (3 [2-5] per hospital) and 14/80 
hospitals improved more than six processes. Mortality-risk documented (57/80 [71%]), lactate 
measurement (42/80 [53%]) and cardiac-output guided fluid therapy (32/80 [40%]) were most 
frequently improved. Consultant-led decision making (14/80 [18%]), consultant review before surgery 
(17/80 [21%]) and time to surgery (14/80 [18%]) were least frequently improved. In hospitals using ≥5 
implementation strategies, 9/30 (30%) hospitals improved 6 care processes compared with 0/11 
hospitals using ≤2 implementation strategies.  
 
Conclusion 
Only a small number of hospitals improved more than half of the measured care-processes, more 
often when at least 5 of 6 implementation strategies were used. In a longer-term project this 
understanding may have allowed us to adapt the intervention to be effective in more hospitals.  
 
 
BACKGROUND 
As the volume of surgical procedures performed worldwide continues to increase [1,2] the need for 
improvement in the quality and safety of surgical care has become a global healthcare priority [3–5]. 
This is of particular importance considering both the increasing age and complexity of the surgical 
population and the global mortality burden associated with surgery [6,7]. Emergency abdominal 
surgery is a commonly performed procedure worldwide, with high mortality rates, and wide variations 
in the standards of care [8–11]. The Enhanced Peri-Operative Care for High-risk patients (EPOCH) trial 
was performed to test whether a national quality improvement (QI) programme to implement a care-
pathway could reduce 90-day mortality following emergency abdominal surgery [12].  
 
The EPOCH trial intervention consisted of an evidence based care-pathway designed to improve 
patient outcomes and a QI programme promoting a set of implementation strategies designed to 
enable care-pathway implementation [13]. The main analyses were designed to evaluate the impact 
of the QI programme across a large cohort of 93 NHS hospitals, leveraging the large sample size to 
adequately power the trial. A different perspective is to view the EPOCH trial QI programme as an 
enabling factor in 93 separate hospital-level QI projects. The impact of local context on the 
effectiveness of QI efforts is increasingly understood, especially in relation to complex intervention 
delivery [14–16]. We observed wide variation in the approaches taken to implement the care-
pathway, including differing ways of engaging colleagues and decisions regarding which parts of the 
pathway to implement first, as well variations in the challenges faced. More details are provided below 
and in  our concurrent trial process and ethnographic evaluation papers [13,17]. Given the level of 
heterogeneity across participating hospitals, an analysis designed to understand changes in care 
processes at the individual hospital level is also needed.  
 
In this paper, we explore how a form of simple time-series chart (the run-chart) might enable detailed 
hospital level analysis of process change over time when system improvements are attempted at a 
national level [18]. The primary objectives of this study were to: 1) evaluate, at the individual hospital 
level, whether participation in the EPOCH trial QI programme led to implementation of the EPOCH 
care-pathway and 2) to assess the relationship between care-pathway implementation and use of the 
implementation strategies. Our secondary objectives were: 1) to describe the number of 
improvements in care processes overall and 2) to describe which care processes were most commonly 
improved (or potentially degraded).  
 
 METHODS 
This was a prospectively designed time series analysis of registry data provided by hospitals 
participating in the EPOCH trial, a stepped-wedge cluster randomised trial across 93 UK National 
Health Service (NHS) hospitals. The registry was the National Emergency Laparotomy Audit (NELA), 
funded separately by the UK Healthcare Quality Improvement Programme, which started collecting 
individual patient data on 1st December 2013.  
 
Patients and hospitals 
Patients were recruited from March 2014 to October 2015. Recruited hospitals were grouped into 15 
clusters of six to eight geographically co-located hospitals; clusters were randomised to start the 
intervention at five-week intervals. QI leads from each stakeholder discipline (surgery, anaesthesia, 
and critical care) were tasked with leading hospital wide improvement to implement the care pathway 
with the support and guidance of the national EPOCH QI team. QI leads were informed of their 
hospitals start date 12 weeks in advance. The main EPOCH trial analysis found no effect on the 
interventions upon any of the trial outcomes measures; 90-day risk adjusted mortality, length of 
hospital stay or hospital readmission [12]. Analysis of trial process measures (see below) suggested 
little improvement had occurred as a result of the intervention across the entire cohort. These results 
did not differ significantly between hospitals activated earlier in the stepped-wedge design compared 
with those activated later. The EPOCH trial was approved by the Research Ethics Committee of the 
NHS (REC reference 13/EM/0415). 
 
The EPOCH care pathway and implementation strategies  
Details of the 37-component evidence based care pathway are provided in Figure 1, and a full 
summary of evidence is available on the trial website (www.epochtrial.org). The EPOCH programme 
theory was based on current evidence and learning from a range of other QI programmes [19–22]. Six 
specific implementation strategies were developed to facilitate care-pathway implementation (see 
Table 1). The EPOCH QI programme was designed to support local clinicians. The programme 
comprised: a one day face-to-face educational meeting; a half-day follow up; a virtual learning 
environment (VLE) and telephone / email support from the core EPOCH team. The QI intervention was 
designed to be “light touch”, recognising the limited resources of the study, of clinician time within 
the NHS and the fact that data collection through NELA was already taking place. Full details of the 
EPOCH QI programme are reported elsewhere [13]. 
 
Data collection  
Data were collected through the NELA database (www.nela.org.uk). Inclusion and exclusion criteria 
for these analyses were the same as for the main trial [12]. Patients were eligible for inclusion in the 
data analysis if they were 40 years or older, and undergoing emergency open abdominal surgery in a 
participating hospital. Patients were excluded from the analysis if they were undergoing a simple 
appendicectomy, surgery related to organ transplant, gynaecological surgery, laparotomy for 
traumatic injury, treatment of complications of recent elective surgery or if they had previously been 
included in the EPOCH trial. We pre-defined a longer data collection period than the main trial, so that 
data from the 1st January 2014 to 31st March 2016 (six months following the end of the EPOCH trial) 
were analysed. The rationale for this is that the shift rule requires at least six data points (i.e. six 
months of data, see below) for change to be demonstrated. There is also evidence that the effects of 
QI may take longer than expected to show [23,24]. Therefore, we included this six-month wash-out 
period to provide clusters activated later in the trial adequate opportunity to demonstrate 
improvement. We used data from our process evaluation questionnaire to quantify recommended 
implementation strategy use in each hospital (Table 1). Full results of the process evaluation are 
reported elsewhere [13]. 77/93 (83%) of QI leads completed the exit questionnaire. For this study, we 
used binary responses related to implementation strategy usage e.g. we did / did not form a QI team.  
 
Process measures 
Process measures in this study are the same as those in the main trial, but now analysed at the 
individual hospital level rather than in a pooled analysis. The 10 key care processes of the EPOCH care-
pathway for which process measure data was available via the NELA dataset were: 1) Consultant-led 
decision making; 2) Consultant review of patient before surgery; 3) Pre-op mortality risk documented; 
4) Time from decision to operate to entrance to the operating theatre; 5) Entry to operating theatre 
within NCEPOD target timeframe; 6) Consultant delivered surgery; 7) Consultant delivered 
anaesthesia; 8) Cardiac output monitoring to guide fluid therapy; 9) Measurement of serum lactate 
intra-operatively; and 10) Admission to critical care post-operatively.  
 
Data analysis  
Process measure data were analysed for each hospital. Data for each calendar month were pooled 
and the mean calculated and plotted onto run charts, using a pre-programmed Excel Workbook 
designed specifically for the EPOCH trial (see Figure 2 for a worked example). A baseline median was 
constructed with the first ten data points (January 2014–October 2014) or from January 2014 up to 
and including the month of trial cluster activation, whichever provided the longer baseline period. To 
increase the likelihood that any signals identified in the run charts were associated with the EPOCH 
trial, and not pre-existing improvement efforts (such as involvement in NELA), each hospital’s baseline 
median was assessed for signals using the run chart rules. In particular the ‘runs rule’ was used to 
identify potential improvements in patient care processes before the improvement intervention 
started (see [18] for the reference chart for this). In line with recommended practice, if no signals were 
seen, the baseline median was fixed and extended forward creating the centre-line for all data points 
on the chart, to facilitate analysis of signals over time [18,25]. Where too few runs were seen, the 
median was not fixed and extended but instead continued with all data points in the chart contributing 
to this. The patterns of data points on the charts were visually inspected for signals compatible with 
accepted run-chart rules which are probability-based, predefined data patterns with a probability of 
<5% of occurring by chance [18]. The two run-chart rules used in this analysis are: 1) a shift, identified 
as a signal with 6 or more data points on one side of the median line and 2) too few runs, identified 
by counting the number of runs (groups of data points falling either above or below the median line), 
and then referring to the published guidance for the upper and lower limits [18]. The trend rule was 
not included due to evidence of lack of utility [25]. When a signal was identified in a care-process, a 
new median monthly delivery rate was calculated based upon the data contributing to the signal. 
 
To answer objective 1, we considered the care-pathway to be implemented if the 10 measured 
processes improved to the extent that all had a median monthly delivery rate of >80% following 
activation to the intervention (or a sustained median of <6 hours to surgery for process measure four, 
as above). Eighty percent was chosen as it is considered a minimum level of process reliability and is 
used by NELA to define an acceptable standard of care [8,26]. Care processes already reliably delivered 
to >80% of patients were also included. To answer objective 2, we defined care-process improvement 
as any signal toward improvement identified on a hospital’s run-chart, regardless of the magnitude of 
the improvement (unless followed by a subsequent signal toward process degradation). For each 
hospital we also calculated the proportion of patients before and after activation to the intervention 
who received each of the target care-processes and the median time from decision to operate to entry 
into the operating theatre (see care-process 4 above) pre and post activation. These were then 
aggregated for all trial hospitals included in the run chart analysis to show the overall effect size of 
process changes. 
 
We report the relationship between care-pathway implementation and implementation strategy 
fidelity using descriptive statistics and analysed the relationship using a scatterplot and R2 calculation. 
To explore this relationship further, we undertook post-hoc analysis comparing: fidelity to 
implementation strategy usage (using 5 or 6 strategies vs. using <5 strategies), individual 
implementation strategy usage, NELA data collection method and care-process improvement 
between the least improved (≤2 care-processes improved; n=28) and the most improved (≥6 care-
processes improved n=14) hospitals. We used Fishers Exact Test, with 2x2 contingency tables to 
compare groupings and a one-sided p-value, with significance set at p<0.05. 
 
We undertook a validation exercise, with an independent reviewer (RH) analysing a random selection 
of 200 of the total 800 charts (25%). The reviewer repeated the analysis of each chart. Results for the 
200 charts were compared with the original analyses and any inconsistencies of analysis discussed, 
and the final result agreed upon. An error rate of ≥5% was decided as the threshold for whether a 
further validation exercise would be necessary. We also undertook two post-hoc sensitivity analyses 
on the charts from the hospitals that improved more than half the process measures (14/80 hospitals 
improved ≥6 care processes) to test the different results obtained by using stricter analysis rules. 
These rules use thresholds for identifying signals (runs and shifts) based upon the total number of data 
points on the chart, rather than a fixed rule, which may provide more accurate findings [27]. In this 
group of most improved hospitals we also undertook analysis using a run chart centre line (median) 
based on all chart data, rather than the fix and extend method. 
 
 
  
RESULTS 
Of the 93 hospitals enrolled in the EPOCH study, 86 hospitals had data available for analysis. However, 
six hospitals had data capture of insufficient quality (<50% case-ascertainment reported via NELA for 
either both Years 1 and 2 of the audit or for the year in which the hospital was activated to the QI 
intervention) to enable month-by-month analysis using run charts. Therefore, 80 hospitals were 
included in analyses resulting in the generation of 800 run charts for the 10 measures of interest, 
based upon analysis of data from 20,305 patient admissions (Figure 3). Table 2 displays key hospital 
characteristics of interest. In the validation exercise, six errors were identified, giving an inter-observer 
agreement of >95%. Of the six errors, three were Type 1 errors, where charts were marked as having 
signals toward improvement that were not there, and two were Type 2 errors, where signals toward 
improvement were missed. One was an error where a degraded care-process was missed (Type 2 
error). In all cases, signals were marginal and overall, these errors did not substantially change our 
main findings or conclusions.  
 
No hospital achieved implementation of the care-pathway according to our definition (all ten 
measured care processes improved to a ≥80% median delivery rate). Regarding objective 2 (describing 
all improvement, not just achievement of >80% reliability), 21/80 hospitals improved  5 of the 10 
measured processes and 14/80 improved ≥ 6. Figure 4 displays the overall number of improved care 
processes per hospital. Pre-operative risk assessment (57/80 [71%]), intra-operative lactate 
measurement (42/80 [53%]) and cardiac-output guided fluid therapy (32/80 [40%]) were the most 
frequently improved care processes (Table 3). Consultant-led decision-making (14/80 [18%]), 
consultant review before surgery (17/80 [21%]) and time from decision to operate to surgery (14/80 
[18%]) were the least likely care processes to improve (Table 3). Questionnaire data describing 
implementation strategy use showed that 10/77 (13%) of QI leads responding said that all six 
strategies had been used, 23/77 (30%) indicated five had been used, 21/77 (27%) indicated four had 
been used, 8/77 (10%) used three strategies, 10/77 (13%) used two and 5/77 (6%) just one. No QI lead 
reported zero implementation strategy usage. Table 1 shows the reported usage of each QI strategy. 
As no hospital achieved care-pathway implementation, we undertook analysis of the relationship 
between implementation strategy usage and the number of care-processes improved. We divided the 
cohort into tertiles of implementation strategy usage (1-2 strategies, 3-4 strategies and 5-6 strategies) 
and defined successful hospitals as those with six or more improved care processes (i.e. more than 
half of care processes improved). In hospitals that used 1-2 strategies, we found that no hospitals 
(0/11) improved six or more care processes, whilst among those that used 3-4 strategies 4/25 (16%) 
hospitals improved six or more care processes, and in those that used 5-6 strategies 9/30 (30%) of 
hospitals improved 6 care processes. However, using a linear analysis model across the whole trial 
cohort, we found no correlation between implementation strategies used and the number of care-
processes improved at individual hospitals (R2 = 0.084, Supplementary File). Figure 5a-c, presents the 
post-hoc analysis findings, comparing least and most improved hospitals by implementation strategy 
usage and NELA data collection method. Prospective NELA data collection, by all members of the care 
team i.e. presenting a lower time-burden for QI leads, was positively associated with greater care 
process improvement (p=0.039). Details of further evaluation of the relationship between care-
process improvement and implementation strategy usage are reported in the supplementary file. 
 
During the analyses we identified the care processes in each hospital that were already reliably 
delivered, as defined by a baseline median of ≥80% delivery of a process measure. Consultant led 
decision making was the care-process most reliably delivered pre-EPOCH, with 71/80 hospitals 
achieving a median of ≥80% for this measure. Of these hospitals 11 (15%) further improved upon this 
performance during the EPOCH intervention period. Consultant delivered surgery was often already 
reliably delivered, with 70/80 hospitals already achieving a median of ≥80% for this measure. 
Nevertheless, 19 of these hospitals (27%) managed to further improve this care-process. Consultant 
delivered anaesthesia was the next most reliably delivered care-process at baseline (57/80 hospitals) 
and 16 of these hospitals (28%) demonstrated further improvement in consultant delivered 
anaesthesia. Conversely, only 2/80 (2.5%) hospitals had a median time from decision to operate to 
surgery of <6hrs before the EPOCH trial started; this was also the most challenging care-process to 
improve, although 17.5% (14/80) of hospitals did demonstrate an improvement on the run chart 
analysis. Process degradation was also observed during run-chart analysis. We found 43/800 (5.4%) 
care processes across 28 hospitals to be degraded after participation in the EPOCH QI programme i.e. 
a signal toward worse performance associated with activation to the EPOCH intervention. Despite 
being the 3rd most frequently improved care-process, use of cardiac output monitoring to guide fluid 
therapy was the most commonly degraded process (10/80 hospitals).  
 
In the sensitivity analyses, using stricter run chart rules would have identified 78/140  care processes 
as improved in this group, rather than 90/140 using the standard rules, resulting in a group of 10 
hospitals, rather than 14 that improved ≥6 care-processes. Regarding different approaches to the 
chart median, 6 / 140 (4%) of charts in the sensitivity analysis used a median based upon all data 
points in the original analysis (due to signals in the baseline period). Across the group of most 
improved hospitals, using a chart centre line based on all data points would have identified 57/140 
(41%) care processes as improved, resulting in a group of 3 hospitals, rather than 14, that improved 
≥6 care-processes (see supplementary Table 1).  
DISCUSSION 
The main finding of this analysis was that no hospital in the EPOCH trial reliably implemented the care-
pathway within six months of the end of the intervention period. However, we did identify areas of 
improvement. In total, 279 (of a possible 800) care processes were improved by hospitals through 
participation in the EPOCH trial and a small group of hospitals (17.5%, 14/80) were successful in 
improving ≥6 care processes. Effect sizes overall were marginal, but with substantial variance for each 
process across trial hospitals. We specifically did not seek to evaluate changes in patient outcomes 
associated with the trial intervention, but it seems logical that if only a small proportion used all the 
recommended implementation strategies and only a sub-set of these hospitals were able to improve 
more than half the target care-pathway processes, then the causal mechanism we hypothesised would 
lead to outcome improvement was largely absent in the EPOCH cohort. This confirms the findings of 
the main, patient level, trial analysis. This supports the use of individual hospital level time-series 
analysis, both during a programme to monitor progress and support hospitals facing challenges, and 
as part of the evaluation strategy to provide granular understanding of cohort-level analyses. We used 
a prospectively defined run chart methodology, but in a sensitivity analysis we found our findings were 
sensitive to the use of alternative methods of run chart construction. 
 
This study contributes to the growing literature on methods to better understand improvement and 
implementation research results in the face of complexity [24,28–30]. In particular, hospitals 
participating in multi-site cohorts may well achieve differing results; understanding this local level 
granularity enables a clearer understanding of what happened during a large-scale intervention and 
what led to, or hindered, overall success [31,32]. In line with evidence that a multi-faceted approach 
to change is more effective [33], the hospital teams in our study that achieved greater care-process 
improvement also reported using more of the implementation strategies recommended by the QI 
programme. Whilst the relationship was absent in the linear model, this approach may be poorly 
suited to the complexity of this issue, especially across a large and heterogenous cohort. Analysis by 
groupings, and in particular when comparing the least and most improved hospitals (Figures 5a-c and 
supplementary file), suggests that greater improvement was possible (but not guaranteed) with use 
of more of the recommended implementation strategies.  This supports the hypothesis that the QI 
intervention could be effective, but only if used in full and deployed within a supportive context. Our 
concurrent process evaluation paper describes in detail the contextual factors, both enablers and 
barriers, faced by hospitals as they attempted improvement [13]. Major barriers included limited time 
and scarce resources to support clinicians leading improvement and, relatedly, an onerous burden of 
data collection which limited capacity to subsequently use these data for improvement. Related to 
this specific factor, our post-hoc analysis also indicated that in hospitals where systems to collect data 
prospectively existed, minimising the data burden on NELA and EPOCH QI leads, the number of 
improved care processes increased. Lack of interest amongst colleagues and seniors was also reported 
as a problem in many hospitals. Almost universally, contextual enablers were the opposite of these 
and future improvement programmes will need to fully address these factors to be successful, 
including allocating job-planned time for frontline improvement leaders and additional funding for 
support functions such as data collection and analysis.  
 
There are other possible reasons why we did not find greater care pathway implementation or care 
process change. Firstly, our definition of reliable pathway implementation may have been too 
stringent. The standards set by NELA only require consultant presence in the operating room and 
admission to critical care for patients with a ≥5% risk of mortality whereas the aspirational 
improvement goal of the EPOCH trial was for all patients requiring emergency abdominal surgery to 
be put onto the recommended care-pathway. Whilst 80% is an accepted threshold for defining 
minimum reliability [26],  it is possible that hospitals were guided by the more pragmatic standards as 
set by NELA, thus reducing the chances of pathway implementation as defined in this paper. Second, 
three key care processes (consultant-led decision making, consultant-delivered surgery and 
consultant-delivered anaesthesia) were already being reliably delivered (to >80% patients) in most 
hospitals at the start of the intervention period, which may have limited the head-room for further 
improvement of these particular care-processes in some hospitals. Also, the value of one key process, 
cardiac output monitoring, was under debate in the UK during the time of the study, [34] and this may 
have meant some teams chose not to focus on it, or as our data shows, to move away from delivering 
this process completely. Third, system level care processes, such as reducing the time to get patients 
into the operating room, were harder to improve than processes that individual clinicians were able 
to improve by themselves, such as assessing mortality risk. Nevertheless, we did see that nearly 30% 
of hospitals improved their performance on getting patients to the operating room in a time-frame 
appropriate for their operative urgency. Considering the complexity of this system-level process, 
contingent on the actions of multiple stakeholders and on the other pressures faced by operating 
room suites in the UK, we feel this is a substantial achievement. This mirrors findings from previous 
QI work regarding the degree of difficulty in attempting to improve systems-level processes compared 
to more discrete, individual professional or small-team delivered processes [35], and supports the 
need to consider different, and potentially more intensive, strategies to improve system-level care 
processes. This may be of particular importance for this patient group given recent evidence 
demonstrating the positive impact upon mortality of system level changes such as single pathways of 
care in emergency general surgery and dedicated emergency surgery units [36].  
 
At the trial level, without these further analyses, the degree to which each hospital had implemented 
the care-pathway as intended or improved would have remained unclear, as each hospital’s signal was 
obscured within the results of a large and heterogeneous cohort. The use of run-charts to evaluate QI 
programmes at scale remains rare, with some notable exceptions [37], yet they are ideally suited to 
this level of granular data analysis. The main strength of this analysis is that we have tested this 
approach experientially, alongside our main trial analyses, using the same dataset, and found it was 
largely congruent with, but added value to, our previous understanding of what happened during the 
EPOCH trial. We mitigated against human error, inherent in the visual inspection of run-charts (present 
even when using automated data analysis programmes), by undertaking a validation exercise to 
provide assurance of reliability, which we consider a strength of this work. We also tested different 
approaches to constructing and analysing run charts in sensitivity analyses and found that the 
approach used may have a substantial impact on findings. This analysis also had some limitations. 
Firstly, performance of hospitals in 6 of the 15 trial clusters was analysed using run-charts that had a 
baseline median constructed of 10 data points, which is the minimum acceptable number to use the 
probability based run-chart rules [18]. This was due to the trial and the data collection process, via 
NELA, starting nearly contemporaneously thus limiting baseline data in early clusters. Secondly, 
analyses requires decisions about the desired trade-off between sensitivity and the risk of false-
positive signals being identified [18,25]. Both our sensitivity analyses, using stricter analysis rules and 
comparing different methods for creating the chart median, reduced the number of process 
improvements observed. In the latter analysis, this reduction was substantial. If stricter run chart rules, 
or a chart median based upon all data points, had been applied across all analyses, the level of care-
process improvement identified would have been smaller than we found than in our pre-planned 
analysis. Third, variations in the denominator for the monthly plotted percentages sometimes 
interfered with signals in the data e.g. in a month with a small denominator, a few process failures 
may create a data point that breaks a signal that would otherwise indicate a move toward 
improvement. This, combined with the time-bound nature of the analyses, may have led to some real-
world improvements not being identified using the run-charts (i.e. Type 2 errors). Our analysis may 
therefore ultimately have provided an overly conservative estimate of the volume of improvement 
associated with the EPOCH intervention. This problem may have been mitigated by using both run 
charts and Statistical Process Control (SPC) charts in a head to head comparison. Although it would 
have produced further valuable reflections on various types of time-series chart for evaluation, it was 
beyond the scope of these pre-planned analyses to do this. Fourth, some of the analysis of the 
relationship between care process improvement and fidelity to implementation strategies was 
undertaken post hoc, as the lack of care-pathway implementation meant we could not complete our 
pre-planned primary objective. Finally, whilst our process and ethnographic evaluation identified 
several potential enabling strategies and influences, we were not able to quantify these to explore 
their relationship directly with process improvement in these analyses. There may therefore be some 
important missing strategies that we did not include in the original programme theory and were also 
not evaluated in this study. 
 
CONCLUSION 
The EPOCH QI intervention did not achieve reliable care-pathway implementation in any trial hospital 
but was associated with individual improvement of care processes across the cohort and substantial 
improvement in a minority of hospitals. Individual hospital performance analysis using time series 
charts can help granular analysis of data from large, heterogeneous cohorts. This approach allowed 
us to fully understand changes in the delivery of patient care in response to the EPOCH trial 
intervention, but findings may be sensitive to the chosen run-chart design. In a longer-term project 
this understanding may have allowed us to adapt the intervention to be more successful.  
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TABLE 1: EPOCH implementation strategies; desired outcomes, resources and use in individual hospitals  
(QuIP, Quality Improvement Programme; VLE, Virtual Learning Environment; NELA, National Emergency Laparotomy Audit) 
Desired outcomes  Proposed 
implementation 
strategies 
QuIP activities and resources  Implementation strategy usage during the 
intervention period – questionnaire items 
Implementation strategy usage 
during the intervention period – 
questionnaire responses  
Motivation for 
change created 
amongst 
stakeholders and 
improvement goals 
clearly understood 
 
QI leads hold a 
stakeholder 
meeting after 
activation 
(Strategy 1) 
 
 
1. Pre-activation checklist (providing 
guidance for planning of stakeholder 
meeting) 
2. Evidence for QI and need for change 
provided  
3. Presentation on achieving engagement 
Stakeholder meeting 
Did you hold a stakeholder meeting as one 
of your QI activities? E.g. a meeting for all 
professionals involved in patient care 
• 55%  (41/75) : Yes 
• 45%  (34/75) : No 
Inter-professional 
collaboration (IPC) 
fostered  
Each hospital to 
form an inter-
professional 
improvement 
team (Strategy 2) 
4. Team approach promoted 
5. QI leads encouraged to invite colleague 
to EPOCH meetings  
6. EPOCH VLE open to all local QI team 
members  
QI team formation 
At your site, was a formal team created to 
work on QI activities related to EPOCH? 
 
• 60%  (46/77) : Yes 
• 27%  (21/77) : No 
• 13%  (10/77) : Other 
(comments indicated informal 
teams often existed) 
Shared view of 
current performance 
created (‘situational 
awareness’) 
 
QI leads analyse 
their own data 
(NELA data +/- 
case note reviews 
and local audit 
data) and feed 
this back to 
7. Case-note review tool 
8. Training on data for improvement 
9. Training on how to access and analyse 
NELA data 
10. Excel workbook programmed to create 
run charts from NELA data 
11. Secure data sharing site created on VLE 
Data collection and analysis 
After starting EPOCH did you or your 
colleagues download and analyse your local 
NELA data?  
 
If yes, how frequently did you do this? 
 
• 79%  (61/77) :  Yes 
• 21%  (16/77) :  No 
 
 
• 43%  (26/61) : Analysing data 
monthly or bi-monthly 
Desired outcomes  Proposed 
implementation 
strategies 
QuIP activities and resources  Implementation strategy usage during the 
intervention period – questionnaire items 
Implementation strategy usage 
during the intervention period – 
questionnaire responses  
colleagues 
regularly  
(Strategy 3) 
• 57%  (35/61) : Analysing data 
less frequently 
 
Frontline teams 
develop and use 
basic QI skills to 
effect change 
QI leads and 
other team 
members: 
Use time-series 
charts (“run-
charts”)  
(Strategy 4) 
Use the Plan-Do-
Study-Act (PDSA) 
cycles   
(Strategy 5)   
Segment the 
patient pathway 
(Strategy 6) 
 
12. Introduction to QI skills training 
provided  
13. Links to further reading and training 
resources for QI 
14. Telephone and email support 
Run-charts 
When analysing data, did you use run-
charts? 
 
PDSA approach 
Did you or your colleagues use the "Plan Do 
Study Act" (PDSA) cycle approach during 
your QI activities? 
 
Pathway segmentation 
Please indicate statement most closely fits 
your hospitals improvement or 
implementation activity during EPOCH 
 
• 92%  (56/61) : Used run-charts 
to analyse data 
 
• 61% (45/74) :  Yes, sometimes            
• 5%   (4/74) : Yes, often 
• 34% (25/74) : No 
 
• 22% (17/77) : We introduced a 
single pathway of care (across 
Pre, Intra and Post-operative 
phases)  
• 32%  (25/77) : We introduced 
separate pathways or care 
bundles for the peri-op phases   
• 40% (31/77) : We focused on 
introducing individual / 
separate interventions  
• 5% (4/77) : Other  
Table 2: Key characteristics of data set.  
Data presented median (IQR), mean (SD) or n (%). 
 
 
 
 
  
Key Hospital Characteristics [38]  
No. of operating theatres / 100 
hospital beds  
2.5 (2.1 – 3.0) 
No. of surgical critical care beds / 
100 beds  
2.7 (2.1 – 3.5) 
Emergency laparotomy volume 
(Years 2014/15)  
271 (204 – 371) 
No. of secondary / tertiary referral 
hospitals  
Secondary 58/80 
Tertiary 22/80 
Key Patient Characteristics  
Age  68 (13) 
Sex – Female 11101 (53%) 
P-Possum Score  7.6 (2.9 – 22.7) 
Table 3: Process measure improvement per hospital temporally associated with participation in the EPOCH trial QI programme 
 Data signals (shifts and runs) identified on run chart analysis  
Care Processes  Number (%) of 
hospitals with 
care process 
improvement  
Observed 
n  
N=80 
  Number (%) of hospitals 
with median baseline care 
process delivery ≥80%  
n 
N=80 
Number (%) of 
hospitals with 
degraded care-
process after 
activation to EPOCH 
n 
N=80 
% difference post intervention vs. pre 
intervention (median, IQR, range) 
1. Consultant led decision making 
14 (17.5%) 71 (88.8%) 6 (7.5%) 
0.44 
  (2.53 - 3.35,  -16.19  - 20.33)   
2. Consultant review of patient before 
surgery 
17 (21.25%) 14 (17.5%) 4 (5%) 
2.4109 
  (-3.67  - 6.37,  -18.19  -  17.73) 
3. Pre-op risk assessment documented 
57 (71.25%) 6 (7.5%) 3 (3.8%) 
13.66 
  (3.25  - 23.48,   - 21.75 -   52.15 ) 
4. Time from decision to operate (DTO) 
to entrance to the operating theatre 14 (17.5%) 2 (2.5%) 5 (6.3%) 
Time in hrs 
-0.500   
(-1.30 -  0.37,   -8.25 - 3.4083 )  
5. Time to Theatre within NCEPOD 
timeframe 
22 (27.5%) 32 (40%) 2 (2.5%) 
8.391   
(1.65 - 12.18,  -7.81 - 25.65)   
6. Consultant delivered surgery 
24 (30.0%) 70 (87.5%) 2 (2.5%) 
1.913   
(-1.96 - 6.52,  -13.86 - 18.66)   
  
  
7. Consultant delivered anaesthesia 
29 (36.25%) 57 (71.3%) 4 (5%) 
3.8416   
(-0.74 - 8.68,  -22.948 - 30.30)   
8. Cardiac output monitoring to guide 
fluid therapy 
32 (40.0%) 3 (3.8%) 11 (13.8%) 
4.766   
(-1.10- 13.25, -29.21 - 50.72)   
9. Measurement of serum lactate 
intra-operatively 
42 (52.5%) 3 (3.8%) 3 (3.8%) 
9.270  
 (2.14  - 17.52,   -28.09 - 39.86)   
10. Admission to critical care post-
operatively 
28 (35.0%) 15 (18.8%) 3 (3.8%) 
2.222 
(-3.62 - 7.33, -17.69 - 26.88)   
Figure 1. The EPOCH trial recommended care-pathway 
Legend: SIRS, Systemic Inflammatory Response Syndrome; Sepsis Six, a protocolised treatment for sepsis; CT, Computer-aided Tomography; WHO, World Health 
Organisation; ABG, Arterial Blood Gas; NMB, Neuro-muscular Blockade; CCOT, Critical Care Outreach Team; NEWS, National Early Warning Score; VTE, Venous Thrombo-
embolism  
 
Figure 2. Run chart analysis process and worked example 
Legend: NELA = National Emergency Laparotomy Audit / CO = Cardiac Output / QI = Quality Improvement 
Explanation of steps in run-chart analysis: 1). Baseline median from month 1 - 11. There are 10 useful data point (excluding 1 point on the median) and 8 runs (groups of 
data points on either side of the median line). Referring to published guidance, this indicates the baseline performance is exhibiting normal (random) variation. 2). As 
the baseline period has no signals, baseline median is projected forward as centre-line for chart, against which to assess new data 3). Intervention period runs from 
month 12 - 27. Two signals of interest: i) number of runs, in this case 5, which when referring to published guidance would indicate a non-random signal and ii) shift, ≥6 
data points on one side of the median line, which would also indicate a non-random signal. Therefore, a signal demonstrating an improved process is shown from 
month 19 onwards. 4) A new median performance is calculated from these data points (71% new median process delivery). 
 
Figure 3. Inclusion of hospitals and patients in the run-chart analysis 
Legend: NELA = National Emergency Laparotomy Audit 
 
Figure 4. Number of care processes improved by each hospital during EPOCH trial (n= 80 hospitals) 
 
 
 
 
 
FIGURE 5a-c: FIGURE 5a : Difference in implementation strategy use between least and most improved hospitals,  FIGURE 5b:  Fidelity to 
implementation intervention, comparing least and most improved hospitals by strategy usage, FIGURE 5c: Comparison of least and most 
improved hospitals by NELA data collection process  
Legend: NELA = National Emergency Laparotomy Audit / QI = quality improvement /PDSA = Plan do Study Act cycles 
 
  
